top of page

OUR STAFF IS TRAINED AND SPECIALIZED  TO PROVIDE OUR VOLUNTEERS AND PATIENTS THE GREATEST EXPERIENCE, AND TO FULFILL THE BEST STANDARDS OF PRACTICE IN THE AREA 

 

Phase II Randomized Double- Blind Placebo Trial to evaluate safety and efficacy of XXX in Diabetes Mellitus 2.

 

Phase 111 Randomized Double- Blind to evaluate the effects of XXX in Postmenopausal woman with Osteoporosis.

 

A Randomized Double- Blind parallel study to evaluate efficacy and safety of XXX as XXX Therapy in Diabetes Mellitus 2.

 

A Phase II Randomized Double- Blind Placebo Controlled Multicenter Trail to evaluate safety and efficacy of XXX for the treatment of Antihypertension in subjects with Hypertension and Diabetes Mellitus I.

 

Gl Randomized Double- Blind study to evaluate the safety and efficacy of XXX in subjects with Arterial Hypertension.

 

Phase II Randomized Double- Blind Placebo study to evaluate efficacy and safety of XXX in subjects with Hypercholesterolemia.

 

Phase III Double -Blind Placebo Controlled to evaluate the efficacy and safety of XXX in subjects with Influenza A.

 

Phase II Randomized Double- Blind Placebo to evaluate the efficacy and safety of XXX in adults with Influenza A.

 

Double Blind Placebo Controlled study to evaluate the safety and efficacy of XXX in subjects with Diabetes Mellitus 1.

 

A Phase I Randomized Double- Blind Placebo Controlled sequential parallel group multiple dose escalation trial to evaluate the safety tolerability pharmacokinetics of 4 once weekly subcutaneous doses of XXX to subjects with type 2 Diabetes Mellitus.

 

A Randomized Double- Blind placebo Controlled study to assess the safety and efficacy of XXX in patients with type 2 Diabetes Inadequately Controlled in Metformin Alone.

 

A study to evaluate the potential incidence of Orthostatic Hypotension in elderly hypertensive patients following administration of a combination of XXX

 

A phase III Randomized Multicenter Double- Blind XXX controlled study assessing the efficacy and safety of oral XXX with Gout.

 

A phase I/II, Randomized, Double-Blind, Placebo controlled, Multicenter Study Evaluating the safety and Pharmacokinetics of Different Dosing Regimens of XXX in Healthy Adults Subjects and Adults Subjects with Uncomplicated Influenza.

 

A Randomized, Double Blind, Placebo- controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with type 2 diabetes or metabolic syndrome.

 

A Phase III b, Randomized, Double-Blind, Multi-Centre Study to Evaluate the Efficacy and Safety of adding XXX to XXX in Incontinent OAB. Subjects who have received XXX for 4 weeks and warrant additional relief for their OAB symptoms.

Some of our Principal Investigator experience in Research

bottom of page